SUNNYVALE, Calif., July 2, 2025 /PRNewswire/ -- Today, Synopsys, Inc. (Nasdaq: SNPS) issued the below statement in connection with the lifting of recent U.S. export...
FREEHOLD, NJ, July 02, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in the ownership and operation of manufactured home communities, is providing investors with an update on the second quarter of 2025 operating results:
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for over 12,000 U.S. and international securities, launched the OTCID™ Basic Market, a major structural upgrade that redefines the baseline for disclosure in the over-the-counter (OTC) equities space.
SAN FRANCISCO, July 01, 2025 (GLOBE NEWSWIRE) -- After hours on June 25, 2025, Connecticut-based private equity firm Compass Diversified (NYSE: CODI) filed a report with the SEC warning investors not to rely on previously issued financial statements for its fiscal years ended- and interim periods within- December 31, 2022 and 2023, citing an expanded scope of previously disclosed accounting irregularities.
HONG KONG, June 30, 2025 /PRNewswire/ -- In a move that has sparked widespread industry discussion, a major mainland Chinese brokerage recently received approval...
NOGALES, Ariz., June 27, 2025 (GLOBE NEWSWIRE) -- – Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that its Board of Directors has authorized a $2.0 million expansion of the Company’s existing share repurchase program.
Explore the financial dynamics of golf’s biggest events in the "Business of Men's Golf Majors 2025" report. Delve into media rights, sponsorships, and prize money, with insights into viewership and social media reach. Highlights include The Open's $86.47M media revenue and PGA's leading sponsorships.
Explore the financial dynamics of golf’s biggest events in the "Business of Men's Golf Majors 2025" report. Delve into media rights, sponsorships, and prize money, with insights into viewership and social media reach. Highlights include The Open's $86.47M media revenue and PGA's leading sponsorships.
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI; the "Company" or “FTAI”) plans to announce its financial results for the second quarter 2025 after the closing of Nasdaq on Tuesday, July 29, 2025. A copy of the press release and an earnings supplement will be posted to the Investor Relations section of the Company's website, https://www.ftaiaviation.com/.
EQT to sell Pioneer, a leading Japanese provider of in-car sound and multimedia products and solutions for global OEMs and the consumer aftermarket, for...
Tryg will conduct pre-close analyst calls and meetings starting on 26 June, ahead of the Q2 2025 results, which will be released on 11 July. This newsletter aims to inform capital market participants of the key factors influencing the company's recent financial performance.
FREEHOLD, NJ, June 23, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, announced that it will host its Second Quarter 2025 Financial Results Webcast and Conference Call. Senior management will discuss the results, current market conditions and future outlook on Thursday, August 7, 2025, at 10:00 a.m. Eastern Time.
The 2025 report on Autoimmune Collaboration & Licensing Deals analyzes 943 agreements from 2016-2025, covering over 30 diseases including MS, RA, lupus, and Crohn’s. Access deal terms, financials, and SEC contracts for top biopharma partnerships. A must-have for benchmarking, due diligence, and strategic planning in autoimmune R&D and commercialization.
The 2025 report on Autoimmune Collaboration & Licensing Deals analyzes 943 agreements from 2016-2025, covering over 30 diseases including MS, RA, lupus, and Crohn’s. Access deal terms, financials, and SEC contracts for top biopharma partnerships. A must-have for benchmarking, due diligence, and strategic planning in autoimmune R&D and commercialization.
MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines
MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines